MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 4.260
+0.150 (3.65%)
Sep 16, 2025, 2:44 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €66.19 million as of September 16, 2025. Its market cap has decreased by -34.74% in one year.
Market Cap
66.19M
Enterprise Value
62.00M
Revenue
3.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.26
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 66.19M, a decrease of -50.13%. That is a compound annual growth rate of -16.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 66.19M | -40.16% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 122.07B |
| Sanofi | 98.20B |
| Sartorius Stedim Biotech | 16.51B |
| bioMérieux | 13.59B |
| Eurofins Scientific SE | 11.34B |
| Ipsen | 9.80B |
| ABIVAX Société Anonyme | 5.34B |
| Virbac | 2.73B |